Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jesse Schold and Susana Arrigain.

 
Connection Strength
  
 
 
5.920
  
  1. Lopez R, Mohan S, Rodrigue JR, Arrigain S, Brosi D, Lavanchy R, Zingmond D, Kaplan B, Pomfret EA, Schold JD. Evaluation of the stability of organ procurement organization performance metrics. Am J Transplant. 2025 Oct; 25(10):2151-2160.
    View in: PubMed
    Score: 0.242
  2. Schold JD, Arrigain S, Husain SA, Yu M, Lopez R, Brosi D, LaVanchy R, Mohan S. Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States. J Am Soc Nephrol. 2025 Oct 01; 36(10):2019-2029.
    View in: PubMed
    Score: 0.242
  3. Schold JD, Hoffman JRH, Mohan S, Gray AL, Lopez R, Arrigain S, Brosi D, LaVanchy R, Husain SA, Yu M, Pomfret EA. Association of the initial implementation of continuous distribution allocation policy with outcomes for lung transplant candidates by blood type. Am J Transplant. 2025 Aug; 25(8):1756-1764.
    View in: PubMed
    Score: 0.240
  4. Giusti S, Arrigain S, Lopez R, Pomfret E, Cervantes L, Schold JD. Evaluating Long-Term Outcomes Among Hispanic Kidney Transplant Recipients. Am J Kidney Dis. 2025 Jul; 86(1):52-62.e1.
    View in: PubMed
    Score: 0.239
  5. Lopez R, Mohan S, Rodrigue JR, Arrigain S, Brosi D, Lavanchy R, Kaplan B, Pomfret EA, Schold JD. Authors' reply to letter regarding "Association of organ procurement organization volume with CMS performance evaluations". Am J Transplant. 2025 May; 25(5):1135-1137.
    View in: PubMed
    Score: 0.237
  6. Lopez R, Mohan S, Rodrigue JR, Arrigain S, Brosi D, Lavanchy R, Kaplan B, Pomfret EA, Schold JD. Association of organ procurement organization volume with Centers for Medicare and Medicaid Services performance evaluations. Am J Transplant. 2025 May; 25(5):1013-1020.
    View in: PubMed
    Score: 0.234
  7. Jackson WE, Lopez R, Forman LM, Arrigain S, Schold JD. Marked variation in disease acuity and outcomes on the liver transplant waiting list by sociodemographic characteristics. Liver Transpl. 2025 May 01; 31(5):584-595.
    View in: PubMed
    Score: 0.232
  8. Lopez R, Mohan S, Husain SA, Yu M, Arrigain S, Brosi D, Hoffman JRH, McCurry KR, Kaplan B, Pomfret EA, Schold JD. Crossing national borders for transplantation: A focused evaluation of deceased donor lung exports from the United States. Am J Transplant. 2025 Feb; 25(2):424-434.
    View in: PubMed
    Score: 0.230
  9. Forman LM, Jackson WE, Arrigain S, Lopez R, Schold JD. Socioeconomic deprivation is associated with worse patient and graft survival following adult liver transplantation. Liver Transpl. 2025 Feb 01; 31(2):211-220.
    View in: PubMed
    Score: 0.226
  10. Zubkov MR, Moore HB, Lopez R, Brosi D, Choudhury RA, Arrigain S, Saben J, Conzen KD, Pomposelli JJ, Pomfret EA, Schold JD. Prognostic value of body mass index is highly modified by sex among recipients of liver transplant. Liver Transpl. 2024 Sep 01; 30(9):962-966.
    View in: PubMed
    Score: 0.225
  11. Schold JD, Conzen KD, Cooper J, Arrigain S, Lopez R, Mohan S, Husain SA, Huml AM, Kennealey PT, Kaplan B, Pomfret EA. Quantifying the Effect of Consent for High-Kidney Donor Profile Index Deceased Donor Transplants in the United States. J Am Soc Nephrol. 2024 May 01; 35(5):630-641.
    View in: PubMed
    Score: 0.222
  12. Amdani S, Boyle G, Rossano J, Scheel J, Richmond M, Arrigain S, Schold JD. Association of low center performance evaluations and pediatric heart transplant center behavior in the United States. J Heart Lung Transplant. 2021 08; 40(8):831-840.
    View in: PubMed
    Score: 0.183
  13. Poggio ED, Augustine JJ, Arrigain S, Brennan DC, Schold JD. Long-term kidney transplant graft survival-Making progress when most needed. Am J Transplant. 2021 08; 21(8):2824-2832.
    View in: PubMed
    Score: 0.180
  14. Tsuang WM, Arrigain S, Lopez R, Snair M, Budev M, Schold JD. Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study. Transplantation. 2020 11; 104(11):2365-2372.
    View in: PubMed
    Score: 0.177
  15. Tsuang WM, Arrigain S, Lopez R, Budev M, Schold JD. Lung transplant waitlist outcomes in the United States and patient travel distance. Am J Transplant. 2021 01; 21(1):272-280.
    View in: PubMed
    Score: 0.174
  16. Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED. Dramatic secular changes in prognosis for kidney transplant candidates in the United States. Am J Transplant. 2019 02; 19(2):414-424.
    View in: PubMed
    Score: 0.152
  17. Augustine JJ, Arrigain S, Balabhadrapatruni K, Desai N, Schold JD. Significantly Lower Rates of Kidney Transplantation among Candidates Listed with the Veterans Administration: A National and Local Comparison. J Am Soc Nephrol. 2018 10; 29(10):2574-2582.
    View in: PubMed
    Score: 0.151
  18. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21.
    View in: PubMed
    Score: 0.129
  19. Navaneethan SD, Kirwan JP, Arrigain S, Schold JD. Adiposity measures, lean body mass, physical activity and mortality: NHANES 1999-2004. BMC Nephrol. 2014 Jul 08; 15:108.
    View in: PubMed
    Score: 0.114
  20. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sarnak MJ, Schold JD. Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol. 2012; 36(3):219-27.
    View in: PubMed
    Score: 0.100
  21. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504.
    View in: PubMed
    Score: 0.089
  22. Budhiraja P, Schold JD, Lopez R, Arrigain S, Kaplan B. Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants. Front Nephrol. 2024; 4:1518791.
    View in: PubMed
    Score: 0.059
  23. Abidi MZ, Lopez R, Arrigain S, Weinberg A, Kaplan B, McAdams-DeMarco M, Schold JD, Erlandson KM. Area-Level Social Deprivation and Cytomegalovirus Seropositivity at the Time of Solid Organ Transplant. JAMA Netw Open. 2024 10 01; 7(10):e2437878.
    View in: PubMed
    Score: 0.058
  24. Park SY, Bashian E, Vigneshwar N, David EA, Randhawa SK, Meguid RA, Mitchell JD, Gray AL, Arrigain S, Pomfret EA, Schold JD, Cain MT, Hoffman JRH. Significantly reduced patient and graft survival for left vs right donor lungs for lung transplant recipients. JHLT Open. 2024 Nov; 6:100148.
    View in: PubMed
    Score: 0.058
  25. Nakhoul GN, Taliercio JJ, Bassil EH, Arrigain S, Schold JD, Wardrop R, O'Toole J, Nally JV, Bierer SB, Sedor JR, Mehdi A. Virtual Nephron: Evaluation of a Novel Virtual Reality Educational Tool. Kidney Int Rep. 2024 Sep; 9(9):2619-2626.
    View in: PubMed
    Score: 0.057
  26. Bilen Y, Schold JD, Arrigain S, Buchalter RB, Huml AM. Relationship of Social Deprivation Among Living Kidney Donor-Recipient Pairs. Transplant Direct. 2024 Jan; 10(1):e1559.
    View in: PubMed
    Score: 0.055
  27. Bassil E, Matta M, El Gharably H, Harb S, Calle J, Arrigain S, Schold J, Taliercio J, Mehdi A, Nakhoul G. Cardiac Surgery Outcomes in Patients Receiving Hemodialysis Versus Peritoneal Dialysis. Kidney Med. 2024 Mar; 6(3):100774.
    View in: PubMed
    Score: 0.055
  28. Augustine JJ, Liaqat A, Arrigain S, Schold JD, Poggio ED. Performance of estimated glomerular filtration rate equations in Black living kidney donor candidates. Clin Transplant. 2024 01; 38(1):e15198.
    View in: PubMed
    Score: 0.055
  29. Lehr CJ, Schold JD, Arrigain S, Valapour M. New OPTN/UNOS data demonstrates higher than previously reported waitlist mortality for lung transplant candidates supported with ECMO. J Heart Lung Transplant. 2023 10; 42(10):1399-1407.
    View in: PubMed
    Score: 0.053
  30. Fadel R, Taliercio JJ, Daou R, Layoun H, Bassil E, Fawaz A, Arrigain S, Schold JD, Herlitz L, Simon JF, Mehdi A, Nakhoul G. Urine Sediment Examination: Comparison Between Laboratory-Performed Versus Nephrologist-Performed Microscopy and Accuracy in Predicting Pathologic Diagnosis in Patients with Acute Kidney Injury. Kidney360. 2023 07 01; 4(7):918-923.
    View in: PubMed
    Score: 0.052
  31. Kanaan CN, Layoun H, Kondoleon NP, Fadel R, Mirzai S, Schold J, Arrigain S, Daou R, Mehdi A, Taliercio JJ, Unai S, Kapadia S, Harb S, Nakhoul GN. Comparison of CT acquired cardiac valvular calcification scores in hemodialysis and peritoneal dialysis patients undergoing open heart surgery. Am Heart J Plus. 2023 Jan; 25:100234.
    View in: PubMed
    Score: 0.051
  32. Cholin LK, Schold JD, Arrigain S, Poggio ED, Sedor JR, O'Toole JF, Augustine JJ, Wee AC, Huml AM. Characteristics of Potential and Actual Living Kidney Donors: A Single-center Experience. Transplantation. 2023 04 01; 107(4):941-951.
    View in: PubMed
    Score: 0.051
  33. Hassanein M, Arrigain S, Schold JD, Nakhoul GN, Navaneethan SD, Mehdi A, Sekar A, Tabbara J, Taliercio JJ. Dysnatremias, Mortality, and Kidney Failure in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Kidney Med. 2022 Dec; 4(12):100554.
    View in: PubMed
    Score: 0.051
  34. Cholin L, Ashour T, Mehdi A, Taliercio JJ, Daou R, Arrigain S, Schold JD, Thomas G, Nally J, Nakhoul NL, Nakhoul GN. Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression. BMC Nephrol. 2021 07 15; 22(1):264.
    View in: PubMed
    Score: 0.046
  35. Nakhoul GN, Mehdi A, Taliercio JJ, Arrigain S, Schold JD, Spencer A, Greenfield J, Diwakar A, Snyder G, O'Toole J, Nally JV, Sedor JR, Kao PF, Bierer SB. "What do you think about nephrology?" A national survey of internal medicine residents. BMC Nephrol. 2021 05 21; 22(1):190.
    View in: PubMed
    Score: 0.046
  36. Augustine JJ, Arrigain S, Mandelbrot DA, Schold JD, Poggio ED. Factors Associated With Residual Kidney Function and Proteinuria After Living Kidney Donation in the United States. Transplantation. 2021 02 01; 105(2):372-381.
    View in: PubMed
    Score: 0.045
  37. Navaneethan SD, Kirwan JP, Remer EM, Schneider E, Addeman B, Arrigain S, Horwitz E, Fink JC, Lash JP, McKenzie CA, Rahman M, Rao PS, Schold JD, Shafi T, Taliercio JJ, Townsend RR, Feldman HI. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55.
    View in: PubMed
    Score: 0.044
  38. Click B, Lopez R, Arrigain S, Schold J, Regueiro M, Rizk M. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 07 17; 26(8):1268-1275.
    View in: PubMed
    Score: 0.043
  39. Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S, Schold JD, Vachharajani T, Nally J, Nakhoul GN. Correction to: Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020 Apr 17; 21(1):139.
    View in: PubMed
    Score: 0.043
  40. Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S, Schold JD, Vachharajani T, Nally J, Na Khoul GN. Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020 02 12; 21(1):49.
    View in: PubMed
    Score: 0.042
  41. Lehr CJ, Lopez R, Arrigain S, Schold J, Koval C, Valapour M. The impact of change in definition of increased-risk donors on survival after lung transplant. J Thorac Cardiovasc Surg. 2020 Aug; 160(2):572-581.
    View in: PubMed
    Score: 0.041
  42. Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease. J Am Heart Assoc. 2019 02 05; 8(3):e009980.
    View in: PubMed
    Score: 0.039
  43. Saeed F, Arrigain S, Schold JD, Nally JV, Navaneethan SD. What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104.
    View in: PubMed
    Score: 0.039
  44. Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV, Nakhoul GN. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron. 2019; 141(1):31-40.
    View in: PubMed
    Score: 0.038
  45. Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV, Navaneethan SD. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
    View in: PubMed
    Score: 0.038
  46. Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
    View in: PubMed
    Score: 0.037
  47. Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322.
    View in: PubMed
    Score: 0.036
  48. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427.
    View in: PubMed
    Score: 0.035
  49. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281.
    View in: PubMed
    Score: 0.035
  50. Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1204-1210.
    View in: PubMed
    Score: 0.035
  51. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV. Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
    View in: PubMed
    Score: 0.034
  52. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46.
    View in: PubMed
    Score: 0.032
  53. Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82.
    View in: PubMed
    Score: 0.032
  54. Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV, Navaneethan SD. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63.
    View in: PubMed
    Score: 0.031
  55. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27.
    View in: PubMed
    Score: 0.030
  56. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8.
    View in: PubMed
    Score: 0.030
  57. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20.
    View in: PubMed
    Score: 0.030
  58. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015 May 03; 16:69.
    View in: PubMed
    Score: 0.030
  59. Liu F, Bennett S, Arrigain S, Schold J, Heyka R, McLennan G, Navaneethan SD. Patency and Complications of Translumbar Dialysis Catheters. Semin Dial. 2015 Jul-Aug; 28(4):E41-7.
    View in: PubMed
    Score: 0.030
  60. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25.
    View in: PubMed
    Score: 0.028
  61. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74.
    View in: PubMed
    Score: 0.028
  62. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV. Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol. 2014; 39(4):288-96.
    View in: PubMed
    Score: 0.028
  63. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63.
    View in: PubMed
    Score: 0.028
  64. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.028
  65. Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10.
    View in: PubMed
    Score: 0.026
  66. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52.
    View in: PubMed
    Score: 0.026
  67. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Sarnak MJ, Nally JV. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34.
    View in: PubMed
    Score: 0.025
  68. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402.
    View in: PubMed
    Score: 0.023
  69. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Simon JF, Srinivas TR, Nally JV. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43.
    View in: PubMed
    Score: 0.023
  70. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ, Jain A, Nally JV. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol. 2011 Jan; 6(1):40-9.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)